Treating Recurrent Tricuspid Regurgitation and Iatrogenic Atrial Septal Defect

Tillmann Kerbel; Markus Mach; Anna Bartunek; Philipp Bartko; Martin Andreas

doi:10.1016/j.jaccas.2023.101775

Treating Recurrent Tricuspid Regurgitation and Iatrogenic Atrial Septal Defect

JACC Case Rep. 2023 Apr 19:12:101775. doi: 10.1016/j.jaccas.2023.101775.

Authors

Tillmann Kerbel¹, Markus Mach¹, Anna Bartunek², Philipp Bartko³, Martin Andreas¹

Affiliations

¹ Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
² Division of Cardiothoracic and Vascular Anesthesia, Medical University of Vienna, Vienna, Austria.
³ Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Abstract

Heterotopic caval valve implantation may be a reasonable option for alleviating symptoms in select high-risk patients with recurrent tricuspid regurgitation after failed interventional tricuspid valve repair. However, altered right atrial hemodynamic status should be considered in procedural planning to avoid potential right-left shunting in cases of septal defects. (Level of Difficulty: Advanced.).

Keywords: CAVI; transcutaneous tricuspid valve intervention; tricuspid regurgitation; valvular heart disease.

Publication types

Case Reports